Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | 4th Annual Drug Delivery Systems Conference - Bharatbook.comDrug delivery is an ever-evolving issue which directly affects the profi tability of your product
By: Bharat Book Bureau But an effective policy on drug delivery is fraught with potential misunderstandings. At what stage should drug delivery considerations be taken in to account? Are the difficulties inherent in proving novel methods a risk worth taking? Should development and production be outsourced or developed in-house? How are successful candidates for partnerships identified? 4th Drug Delivery Conference is the opportunity to hear industry experts discuss these business-critical issues. As well as updates on the latest research and technological advances, practical business issues such as maximising return from alliances and early incorporation of drug delivery considerations in the drug development cycle will be considered. Reasons you cannot afford to miss this event : Hear about the latest drug delivery technologies and develop strategies on how they can be used to meet key unmet needs and maximize market access. Learn to maximise ROI on products by understanding how the issue of drug delivery and reformulation inter-relates with discovery, and applying this knowledge to early stage considerations in drug development. Evaluate different strategies on managing a drug delivery alliance, and hear recommendations on contractual arrangements, aligning business goals and making the most of your shared strengths. Network with key industry players to form these business-critical alliances. Register today to avoid missing out on this opportunity to maximise your business potential! I look forward to meeting you at the conference. Best regards, Sara Feast Conference Producer Pharmaceutical Division ----------------------------------------------------------- Who should attend : • Pharmaceutical and biotechnical companies • Drug delivery systems manufacturers • Specialty pharmaceutical companies • Medical device manufacturers • Research institutes and associations • Universities/ • Consultants • Venture capitalist companies/ Investment banks/ Analysts Who will be there : Vice-Presidents, CEOs, CSOs, CTOs, Directors, Heads and Managers of: • Pharmaceutical research and development • Drug Delivery/ Drug Delivery Systems • Formulation Sciences/ Formulation/ • Exploratory Development/ • Analytical Development/ • Licensing Strategy/ External Research • Product Lifecycle Management ----------------------------------------------------------- Day 1 - 4TH ANNUAL DRUG DELIVERY SYSTEMS - WED 30TH JANUARY 2008 09:00 Registration and refreshments 09:30 Opening address from the chair Professor John Smart Head of School of Pharmaceuticals and Biomolecular Sciences University of Brighton 09:40 Successful partnering of drug delivery projects • Deciding when and what to partner • How to fi nd the right partner • Management of the alliance to achieve success Dr Francesco Patalano Managing Director Europe SkyePharma 10:20 Extending product life cycle through novel drug delivery systems • Maximising ROI through reformulation of drug delivery systems • Protecting your patent through innovation • Assessing potential revenues gains by implementing novel drug delivery techniques Dr Frank Grams Global Head of Drug Delivery Partnering Roche 11:00 Morning refreshments 11:20 Injecting Drugs and Vaccines in a Solid Dosage Form • Benefi ts of injecting drugs and vaccines in a solid dosage form • Currently marketed technologies for the injection of solid drugs • The PowderJect technology • The Glide SDI (Solid Dose Injector) Dr Charles Potter CEO GlidePharma 12:00 Getting to market: registering, protecting and exploiting your invention • Regulatory review: how do regulators view innovative drug delivery systems? What expectations do they have? • Drug delivery and IP; how can innovative DD mechanisms help manage a product’s life cycle? • Specific issues: DD and the EU Paediatric Regulation and Orphan Drug Designation Marc Dalby Associate Lovells 12:40 Networking lunch 14:00 Formulation strategies based on supercritical fluid technology for delivery of biopharmaceuticals • Development of new delivery systems for biopharmaceuticals: • New formulation strategies for biopharmaceuticals based on supercritical fluid (SCF) technology • Design and production of micro- and nanoparticles for biopharmaceutical delivery using SCF processes • SCF process scalability and production under pharmaceutical cGMP standards Dr Joel Richard Director, Pharmaceutical Development Merck-Serono 14:40 Delivery of monoclonal antibodies • Market situation of mAB-Based therapeutics • The need of high mAb-concentration • Managing the administration of large doses • Maintaining stability at high concentrations • Identifying successful formulations for antibody-based therapeutics • Safety aspects of the excipients used in antibodyformulation Dr Stefan Bassarab Director of Pharmaceutical Development Boehringer-Ingelheim 15:20 Afternoon refreshments 15:40 siRNA as a Therapeutic Modality: Delivery is Key • siRNA is being developed as a therapeutic modality • Delivery to peripheral organs such as the lung and eye is already possible • Tissue targeted delivery is key to wider utility of siRNA in treating disease Dr Tim Sparey Associate Director, Scientifi c Liason Merck 16:20 Mono-substituted cyclodextrins in ocular reformulation • Overcoming the challenges of hydrophobicity and improving drug delivery • Enhancing the aqueous solubility of drug candidate; • Identifying suitable cyclodextrin derivatives • Defi ning optimal molar rations of cyclodextrin • Potential candidates include steroids, peptides, natural compounds and a host of small to large molecular weight drug candidates • Benefi ts of cyclodextrin as a non-irritating eye-drop formulation Dr Richard White Director of Toxicology and Pharmacology OphthalmoPharma 17:10 Closing remarks from the chair 17:15 Networking drinks Take your discussions further and build new relationships in a relaxed and informal setting. For more information, please visit : http://www.bharatbook.com/ Website: www.bharatbook.com End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number